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Objectives. This study sought to assess the effects of sequential
coronary artery occlusion during minimally invasive coronary
artery bypass graft surgery (CABG) on hemodynamic variables
and left ventricular systolic function by means of transesophageal
echocardiography (TEE).
Background. Clinical and experimental studies suggest a pro-
tective effect of ischemic preconditioning in patients with acute
coronary syndromes. However, the effect of repetitive myocardial
ischemia on myocardial mechanical function in humans is not
completely understood.
Methods. Seventeen patients with left anterior descending
coronary artery (LAD) stenosis >270% and normal rest left
ventricular systolic function referred for minimally invasive
CABG underwent intraoperative TEE for assessment of regional
left ventricular wall motion and measurement of hemodynamic
variables at baseline (baseline 1), during a 5-min coronary
occlusion (occlusion 1), after a 5-min reperfusion period (baseline
2) and a during a second coronary occlusion during bypass
anastomosis (occlusion 2).
Results. Left ventricular wall motion score (LVWMS) increased
significantly from baseline (16.0) to occlusion 1 (21.4 6 3.1
[mean 6 SD], p < 0.05) and occlusion 2 (21.8 6 3.1, p < 0.05). No
difference in LVWMS was noted between occlusions 1 and 2.
Pulmonary artery systolic pressure increased significantly from
baseline (25 6 6 mm Hg) to occlusion 1 (32 6 7 mm Hg, p < 0.05)
and occlusion 2 (33 6 6 mm Hg, p < 0.05). Pulmonary artery
diastolic pressure also increased significantly from baseline (12 6
4 mm Hg) to occlusion 1 (16 6 4 mm Hg, p < 0.05) and occlusion
2 (16 6 4 mm Hg, p < 0.05). No significant differences in
pulmonary artery pressures were noted between occlusions 1 and
2.
Conclusions. Ischemic dysfunction was precipitated by the
5-min LAD occlusion, as shown by the increase in LVWMS and
pulmonary artery pressure. However, a 5-min coronary occlusion
and the resulting ischemia do not alter regional left ventricular
systolic function during subsequent ischemia in humans.
(J Am Coll Cardiol 1998;31:1035–9)
©1998 by the American College of Cardiology
Experimental animal models support ischemic preconditioning
as a mechanism that limits myocardial necrosis resulting from
coronary occlusion (1–4). Thus, ischemic preconditioning may
account for the clinical observations relating to preinfarction
angina and smaller infarct size in acute coronary syndromes
(5–8). In addition, ischemia has been reported to diminish
during repeated occlusions in patients undergoing percutane-
ous transluminal coronary angioplasty (PTCA) (9–13). How-
ever, the effect of repetitive ischemia on myocardial mechan-
ical function in humans is not well understood (9,14).
Minimally invasive coronary artery bypass graft surgery
(CABG) involves bypassing a coronary artery under direct
visualization (15). The procedure avoids cardiopulmonary
bypass, and the anastomosis is performed on a beating heart
while the recipient vessel is occluded. A brief test occlusion is
often done and released before the anastomosis. Intraopera-
tive transesophageal echocardiography (TEE) during mini-
mally invasive CABG provides a unique opportunity to study
the effects of coronary occlusion on myocardial function. We
hypothesized that the extent and severity of regional dysfunc-
tion during occlusion for anastomosis would decrease after a
5-min test occlusion. Thus, the present study reports the effects
of sequential coronary occlusion on hemodynamic variables
and left ventricular regional function as assessed by TEE
during minimally invasive CABG.
Methods
Study group. Twenty-three patients referred for minimally
invasive CABG of the left anterior descending coronary artery
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(LAD) between March 1, 1996 and August 15, 1996 were
evaluated for the study. All patients had significant intralumi-
nal obstruction ($70%) of the LAD by coronary angiography.
In addition, all patients underwent intraoperative TEE as part
of the minimally invasive CABG procedure and were assessed
for the development of segmental wall motion abnormalities in
the anterior or apical regions, or both, during an intraoperative
preliminary 5-min LAD occlusion. Six patients were excluded
from the study. Three patients had baseline akinesia or hypo-
kinesia in the LAD territory or .70% right coronary artery
stenosis (n 5 2), or both, and three patients did not display
regional dysfunction during the initial coronary occlusion,
leaving 17 patients for analysis (Table 1).
Minimally invasive CABG. The operation was performed
through a 6- to 8-cm left submammary incision. The fourth
costal cartilage was removed, providing direct access to the left
internal mammary artery (LIMA) and avoiding the need for
rib spreading. The LIMA was mobilized under direct vision
from the first to fifth rib with the help of a mechanical retractor
to lift the third rib. Heparin (5,000 U) was given intravenously
before dividing the distal end of the LIMA pedicle. The
pericardium was opened and pulled up to the chest wall with
sutures. The middle portion of the LAD was identified and
uncovered for a distance of 2 to 3 cm. The vessel was encircled
proximally and distally with Silastic loops mounted on a blunt
needle. A 5-min test occlusion followed by a 5-min period of
reperfusion was performed in each patient to determine the
degree of hemodynamic disturbance caused by coronary occlu-
sion and to serve as a potential means of ischemic precondi-
tioning. The LAD was opened using a standard coronary
scalpel and scissors, and the anastomosis was achieved with a
running 7-0 polypropylene suture. Intercostal rib blocks with
0.25% bupivicaine were given to each patient to provide
immediate pain control, which allowed extubation in the
operating room immediately after wound closure.
Echocardiography. Intraoperative TEE was performed in
all patients. The left ventricle was imaged from the transesoph-
ageal four-chamber, two-chamber and long-axis views and the
transgastric short-axis and long-axis views (16). Baseline imag-
ing was performed after induction of anesthesia but before the
initial incision. Imaging was also performed during the 5-min
coronary occlusion (occlusion 1), after the 5-min reperfusion
period (baseline 2), during the 10 to 12 min anastomosis period
(occlusion 2) and after graft anastomosis (recovery). Images
were obtained during the last 2 min of occlusion 1. The
transesophageal four-chamber, two-chamber and long-axis
views were obtained in sequence and were followed by the
transgastric short- and long-axis views. Imaging for occlusion 2
started 3 min into the stage utilizing the identical sequence
used during occlusion 1, followed by continuous imaging in the
view or views showing the greatest regional dysfunction. Left
ventricular regional wall motion was evaluated by two investi-
gators (H.J.M., C.M.K.) who had no knowledge of the clinical
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
ECG 5 electrocardiogram, electrocardiographic
LAD 5 left anterior descending artery
LIMA 5 left internal mammary artery
LVWMI 5 left ventricular wall motion index
LVWMS 5 left ventricular wall motion score
PTCA 5 percutaneous transluminal coronary angioplasty
TEE 5 transesophageal echocardiography (echocardiographic)
Table 1. Patient Characteristics
Pt No./
Gender
Age
(yr)
LAD
(% stenosis)
Collateral Channels
Present
LVEF
(%)
LVWMS
BL Occl 1 Occl 2
1/M 58 100 No 55 16 18 18
2/M 73 95 No 55 16 20 20
3/M 47 95 No 60 16 20 22
4/M 72 90 No 65 16 21 22
5/M 73 70 No 55 16 24 24
6/M 65 85 No 60 16 18 18
7/F 60 95 No 55 16 25 25
8/M 70 80 No 65 16 24 26
9/M 56 100 No 65 16 20 20
10/M 61 100 No 60 16 18 19
11/M 79 95 No 60 16 22 22
12/M 51 95 Yes 55 16 28 28
13/M 76 80 No 60 16 18 18
14/F 52 90 No 55 16 25 25
15/F 73 90 No 55 16 21 21
16/F 47 95 Yes 60 16 24 24
17/F 80 80 No 60 16 18 19
Mean 6 SD 64 6 11 90 6 8 59 6 4 16 6 0 21.4 6 3.1 21.8 6 3.1
F 5 female; LAD 5 left anterior descending coronary artery; LVEF 5 left ventricular ejection fraction at baseline
(BL); LVWMS 5 left ventricular wall motion score; M 5 male; Occl 5 occlusion; Pt 5 patient.
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information and stage of procedure. Utilizing the 16-segment
model, regional wall motion was indexed (1 5 normal; 2 5
hypokinesia; 3 5 akinesia; and 4 5 dyskinesia), as previously
described (17). A left ventricular wall motion score (LVWMS)
was calculated by adding the regional index from the 16
segments for each occlusion. In addition, a baseline qualitative
left ventricular ejection fraction was reported as previously
described (17). Interobserver variability was minimal for the
LVWMS (r 5 0.98, p , 0.0001). Disagreement in the left
ventricular wall motion index (LVWMI) was present in 2% of
the segments analyzed. Disagreements regarding the LVWMS
and the LVWMI were resolved with a third experienced reader
(S.T.P.) by consensus.
Hemodynamic variables. Intraoperative hemodynamic
variables were recorded at each stage of the procedure.
Baseline 1, occlusion 1 and occlusion 2 pressures were com-
pared because baseline 2 pressures were not consistently
recorded. Systolic and diastolic blood pressures were obtained
from an arterial catheter. Pulmonary artery systolic and dia-
stolic pressures were obtained from a pulmonary artery cath-
eter that was placed preoperatively in the operating suite.
Statistical analysis. The Friedman repeated measures
analysis of variance on ranks was used to assess statistical
significance of changes in LVWMS, LVWMI and pulmonary
artery pressures. Post hoc multiple pairwise comparisons were
provided by the Student-Newman-Keuls test. Differences in
regional LVWMI between occlusion 1 and occlusion 2 stages
were evaluated with the Wilcoxon signed rank test. A p value
#0.05 was considered statistically significant.
Results
Patient characteristics. The study included 17 patients (12
men, 5 women; mean age 64 6 11 years) who underwent
minimally invasive CABG (Table 1). The percent LAD steno-
sis ranged from 70% to 100% (mean stenosis 90 6 8%).
Angiographic collateral channels were present in two patients.
Baseline left ventricular ejection fraction by echocardiography
was 59 6 4%. Nine patients presented with stable and eight
with unstable angina.
Echocardiographic findings. LVWMS was significantly dif-
ferent (p # 0.001) among the four stages and was significantly
higher during occlusion 1 than during baseline 1 (16.0 6 0 vs.
21.4 6 3.1, p , 0.05). After reperfusion in which left ventric-
ular function returned to normal (baseline 2), there was a
statistically significant increase in LVWMS after occlusion 2
(16.0 6 0 vs. 21.8 6 3.1, p , 0.05). No significant change was
observed between occlusions 1 and 2 (Fig. 1). Postoperative
left ventricular function returned to normal (LVWMS 16.0 6
0) in all patients after revascularization.
Statistically significant differences (p # 0.001) were ob-
served in LVWMI among the four stages for the anteroapical,
apicoseptal, midanteroseptal and midanterior regions. In each
case, occlusion 1 resulted in regional dysfunction in the
anteroapical and apicoseptal regions (Fig. 2). There were
statistically significant increases in LVWMI from baseline to
occlusions 1 and 2 for both the anteroapical and apicoseptal
regions. In the anteroapical region, LVWMI increased from
1.0 at baseline 1 to 3.1 6 0.9 (p , 0.05) at occlusion 1 and from
1.0 for baseline 2 to 3.2 6 0.9 (p , 0.05) at occlusion 2.
Likewise, in the apicoseptal region, LVWMI increased from
1.0 at baseline 1 to 2.8 6 0.8 (p , 0.05) at occlusion 1 and from
1.0 at baseline 2 to 2.8 6 0.8 (p , 0.05) at occlusion 2.
Dysfunction was observed in the midanterior region in 65% of
patients during occlusions 1 and 2, with a statistically signifi-
cant increase in LVWMI from baselines 1 and 2 (1.0) to
occlusions 1 (1.8 6 0.9, p , 0.05) and 2 (1.8 6 0.9, p , 0.05).
Figure 2. LVWMI at baseline 1, occlusion 1, baseline 2 and occlusion
2. Statistically significant differences (p # 0.001) were observed in
LVWMI among the four stages for the anteroapical (solid bars),
apicoseptal (gray bars), midanteroseptal (open bars) and midanterior
(hatched bars) regions. By pairwise multiple comparison procedures,
there were statistically significant differences (p , 0.05) between
baseline 1 and occlusion 1 and between baseline 2 and occlusion 2. No
significant change was observed between occlusions 1 and 2 in these
regions. *p , 0.05 versus baseline 1. †p , 0.05 versus baseline 2.
Figure 1. LVWMS at baseline 1, occlusion 1, baseline 2 and occlusion
2. LVWMS was significantly different (p # 0.001) among the four
stages. By pairwise multiple comparison procedures, there were sig-
nificant differences between baseline 1 and occlusion 1 (p , 0.05) and
between baseline 2 and occlusion 2 (p , 0.05). No significant change
was observed between occlusions 1 and 2. *p , 0.05 versus baseline 1.
†p , 0.05 versus baseline 2.
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Similarly, dysfunction was observed in the midanteroseptal
region in 41% of patients during occlusions 1 and 2, with a
statistically significant increase in LVWMI from 1.0 at base-
lines 1 and 2 to 1.8 6 1.0 (p , 0.05) at occlusions 1 and 2.
However, there were no significant differences in LVWMI
between occlusions 1 and 2.
Hemodynamic variables. Pulmonary systolic pressure in-
creased significantly from baseline (25 6 6 mm Hg) to
occlusion 1 (32 6 7 mm Hg, p , 0.05) and occlusion 2 (33 6
6 mm Hg, p , 0.05). Pulmonary diastolic pressure also
increased significantly from baseline (12 6 4 mm Hg) to
occlusion 1 (16 6 4 mm Hg, p , 0.05) and occlusion 2 (16 6
4 mm Hg, p , 0.05). No significant change in pulmonary artery
pressure was noted between occlusions 1 and 2.
Systolic blood pressure did not change significantly from
baseline (120 6 9 mm Hg) to occlusion 1 (115 6 10 mm Hg)
or occlusion 2 (116 6 10 mm Hg). Diastolic blood pressure did
not change from baseline (65 6 8 mm Hg) to occlusion 1 (64 6
8 mm Hg) or occlusion 2 (65 6 7 mm Hg).
Discussion
Despite the precipitation of ischemia shown by the devel-
opment of left ventricular regional dysfunction and an increase
in pulmonary artery pressure, the 5-min preliminary occlusion
of the LAD during minimally invasive CABG did not prevent
the development of ischemic regional systolic dysfunction or
pulmonary artery hypertension during a subsequent occlusion.
Our intraoperative TEE results are in agreement with previous
echocardiographic reports that sequential coronary artery oc-
clusion during coronary angioplasty does not result in less left
ventricular regional dysfunction during subsequent occlusions
(14). These data do not detract from the previous observation
that preinfarction angina results in less mortality in patients
who develop acute coronary syndromes (5–7); rather, they
indicate that the extent of systolic dysfunction does not change
significantly after repeated episodes of ischemia.
Preconditioning in clinical cardiology: comparison with
published reports. Angina preceding an acute myocardial
infarction or acute coronary syndrome has been shown (5–7) to
have protective effects for patients with coronary artery dis-
ease. Preinfarction angina or angina of increased frequency
before a clinical event appears to result in a smaller myocardial
infarction, as measured by creatine kinase elevation, fewer Q
wave infarctions, less congestive heart failure, lower mortality
and a greater likelihood of successful thrombolysis (5–7,18,19).
One mechanism proposed for this protective effect is ischemic
preconditioning. Preconditioning is thought to occur as the
result of a metabolic alteration precipitated by brief episodes
of ischemia that have energy-sparing effects, resulting in re-
duced infarct size after total occlusion. This phenomenon has
been demonstrated in multiple experimental models (1–4).
Clinical studies have attempted to demonstrate cardiopro-
tective effects of preconditioning in humans (9–13,14). Studies
utilizing sequential PTCA have examined whether sequential
arterial occlusions result in less myocardial ischemia, with
conflicting results. Deutsch et al. (9) examined 12 patients who
underwent angioplasty of the LAD and reported less electro-
cardiographic (ECG), hemodynamic and metabolic (myocar-
dial lactate production) changes on subsequent coronary oc-
clusions of #90 s. A recent study (13) also demonstrated less
ischemia by intracoronary and surface ECGs with sequential
occlusion of the LAD by PTCA and after pretreatment with
intracoronary adenosine. However, left ventricular wall motion
was not evaluated in these studies.
The findings of the present study are in agreement with the
findings of Dupouy et al. (14) who reported that brief periods
of ischemia from occlusion of the LAD by means of balloon
angioplasty did not protect against subsequent regional ven-
tricular dysfunction as assessed by M-mode transthoracic echo-
cardiography. In addition, hemodynamic variables of ischemia,
including left ventricular end-diastolic pressure, showed simi-
lar increases with subsequent balloon inflations. Additional
studies that assessed the effect of beta-blockade during coro-
nary occlusion did not describe less ischemia as assessed by
ECG, hemodynamic and clinical variables with subsequent
occlusions before the administration of the anti-ischemic drug
(20,21). Finally, Hauser et al. (22) showed that the time to
regional dysfunction as assessed by echocardiography during
coronary angioplasty did not decrease with sequential angio-
plasty balloon inflations.
One potential explanation for differences in the results of
the current study and clinical observations that infarct size is
limited by preinfarction angina may be related to physiologic
differences between ischemic myocardial dysfunction and in-
farction as they relate to preconditioning. Ours was a study of
transient brief ischemia, not infarction. The regional dysfunc-
tion created by the coronary occlusion during minimally inva-
sive CABG completely resolves after revascularization. It is
possible that although there is visible dysfunction seen on
echocardiography, persistent occlusion would result in a smaller
area of irreversibly damaged myocardium or a significant delay in
irreversible cell injury because of the preceding ischemia.
Another potential explanation is the presence of collateral
circulation (23). Collateral circulation is thought to develop in
the presence of a pressure gradient between the coronary bed
distal to an obstruction and a normal or minimally diseased
contralateral coronary artery (24). Coronary angiography does
not estimate the presence or extent of collateral circulation
well, limiting interpretation of studies utilizing angiographic
data to assess differences in outcome related to collateral flow
(25). Clinically significant collateralization that limits ventric-
ular dysfunction was excluded in our study because any patient
whose LVWMI did not change with the initial occlusion was
excluded from the analysis. Techniques such as myocardial
contrast echocardiography may help determine the role of
collateral circulation in limiting infarct size in patients with
preinfarction angina.
Study limitations. It is possible that longer ischemic peri-
ods, longer recovery periods or repetitive episodes of transient
ischemia before minimally invasive CABG may be required to
produce mechanical preconditioning in humans. In addition,
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rather than preservation of systolic function, preconditioning
may limit the metabolic and pathologic effects of prolonged
ischemia, which were not measured in the current study.
Our sample size was small. Using the Wilcoxon signed rank
test, our sample size had a 66% power to detect a change in
LVWMS between occlusions 1 and 2. Although our data
suggest that 24 patients would be required to exclude a difference
between the two stages with 80% certainty, we observed a trend
toward worse LVWMS during occlusion 2. Thus, our data are
consistent with the concept that the initial 5-min ischemic period
did not limit subsequent ischemic regional dysfunction.
Implications. Ischemic preconditioning could be of value
in minimally invasive CABG. One potential benefit of precon-
ditioning would be less systolic dysfunction and greater hemo-
dynamic stability during occlusion of the native coronary artery
for conduit anastomosis. Another potential benefit would be
smaller infarct size should coronary occlusion or thrombosis of
the vessel occur during the surgical procedure. The current
study shows that a 5-min occlusion of the LAD did not result
in less systolic dysfunction during the coronary anastomosis. In
fact, coronary occlusion resulted in severe hypokinesia, akine-
sia and dyskinesia during both occlusions. Thus, surgeons
should not expect a brief period of occlusion to protect against
severe regional systolic dysfunction during coronary occlusion.
Although the 5-min preliminary occlusion of the LAD did not
prevent regional dysfunction during the subsequent occlusion,
hemodynamic variables and regional dysfunction (LVWMS
and LVWMI) tended to stabilize during the second occlusion,
which was longer in duration. Potentially, LVWMI and
LVWMS would have been greater during the second occlusion
if test occlusions were not performed. Finally, in all patients
from our series, complete systolic recovery was observed by
TEE in the early postanastomosis period. Test occlusions may
help permit the early mechanical recovery of systolic function
after revascularization despite our finding of comparable dys-
function during both occlusive periods.
The metabolic effects of coronary occlusion were not as-
sessed during the present study. In a recent study (13),
intracoronary adenosine pretreatment limited the ischemic
effects of PTCA as assessed by intracoronary and surface
ECGs. Future studies assessing the effects of adenosine pre-
treatment on left ventricular function after coronary occlusion
during minimally invasive CABG and PTCA are needed to
define the clinical significance of this finding. In addition, it is
unclear whether medical interventions that alter hemodynamic
variables may improve systolic function or promote precondi-
tioning during minimally invasive CABG.
We gratefully acknowledge the expert statistical analysis of Diane A. Vido, MS,
Research Data Analyst.
References
1. Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a
delay of lethal cell injury in ischemic myocardium. Circulation 1986;75:1124–36.
2. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning
reduces infarct size in swine myocardium. Circ Res 1990;66:1133–42.
3. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with
preconditioning. Circulation 1990;82:609–19.
4. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall
motion as well as smaller infarcts after transient coronary occlusion in
rabbits. Circulation 1991;84:341–9.
5. Kloner RA, Shook T, Przyklenk K, et al.; Previous angina alters in-hospital
outcome in TIMI 4: a clinical correlate to preconditioning? Circulation
1995;91:37–47.
6. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a
role for ischemic preconditioning. Circulation 1995;91:291–7.
7. Anzai T, Yoshikawa T, Asakura Y, et al. Preinfarction angina as a major
predictor of left ventricular function and long-term prognosis after a first Q
wave myocardial infarction. J Am Coll Cardiol 1995;26:319–27.
8. Kloner RA, Yellon D. Does ischemic preconditioning occur in man? J Am
Coll Cardiol 1994;24:1133–42.
9. Deutsch E, Berger M, Kussmaul WG, Hirshfield JW, Herrmann HC, Laskey
WK. Adapation to ischemia during percutaneous transluminal coronary
angioplasty: clinical, hemodynamic and metabolic features. Circulation
1990;82:2044–51.
10. Criber A, Korsatz L, Koning R, et al. Improved myocardial ischemic
response and enhanced collateral circulation with long repetitive coronary
occlusions during angioplasty: a prospective study. J Am Coll Cardiol
1992;20:578–86.
11. Kyriakidis MD, Petropoulakis PN, Tentolouris CA, et al. Relation between
changes in blood flow of the contralateral coronary artery and the angio-
graphic extent and function of recruitable collateral vessels arising from this
artery during balloon coronary occlusion. J Am Coll Cardiol 1994;23:869–78.
12. Kerensky RA, Kutcher MA, Braden GA, Applegate RJ, Solis GA, Little
WC. The effect of intracoronary adenosine on preconditioning during
coronary angioplasty. Clin Cardiol 1995;18:91–6.
13. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning
of human myocardium with adenosine during coronary angioplasty. Circu-
lation 1997;95:2500–07.
14. Dupouy P, Geschwind H, Pelle G, et al. Repeated coronary artery occlusions
during routine balloon angioplasty do not induce myocardial preconditioning
in humans. J Am Coll Cardiol 1996;27:1374–80.
15. Acuff TE, Landreneau RJ, Griffith BP, Mack MJ. Minimally invasive
coronary bypass surgery. Ann Thorac Surg 1996;61:135–7.
16. Seward JB, Khandheria BK, Freeman WK, et al. Multiplane transesophageal
echocardiography: image orientation, examination technique, anatomic cor-
relation and clinical applications. Mayo Clin Proc 1993;68:523–51.
17. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantita-
tion of the left ventricle by two-dimensional echocardiography. J Am Soc
Echocardiogr 1989;2:358–67.
18. Andriotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A.
Preinfarction angina as a predictor of more rapid coronary thrombosis in
patients with acute myocardial infarction. N Engl J Med 1996;334:7–12.
19. Hirai T, Fujita M, Yamanishi K, Ohno A, Miwa K, Sasayama S. Significance
of preinfarction angina for preservation of left ventricular function in acute
myocardial infarction. Am Heart J 1992;124:19–23.
20. Feldman RL, Macdonald RG, Hill JA, Limacher MC, Conti CR, Pepine CJ.
Effect of propranolol on myocardial ischemia occuring during acute coronary
occlusion. Circulation 1986;73:727–33.
21. Zaleweski A, Goldberg S, Dervan JP, Slysh S, Maroko PR. Myocardial
protection during transient coronary occlusion in man: beneficial effects of
regional b-adrenergic blockade. Circulation 1986;73:734–9.
22. Hauser AM, Gangadharan V, Ramos RG, Gordon S, Timmis GC. Sequence
of mechanical, electrocardiographic and clinical effects of repeated coroanry
artery occlusion in human beings: echocardiographic observations during
coronary angioplasty. J Am Coll Cardiol 1985;5:193–7.
23. Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral
vessels on myocardial infarct size in humans: results of Phase I Thrombolysis
in Myocardial Infarction (TIMI) trial. Circulation 1991;83:739–46.
24. Edwards RR, Little WC. Coronary collaterals in acute myocardial infarction
without underlying coronary stenosis. Am Heart J 1990;120:424–7.
25. Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional
significance of collateral blood flow in patients with recent acute myocardial
infarction: a study using myocardial contrast echocardiography. Circulation
1992;85:2080–9.
1039JACC Vol. 31, No. 5 MALKOWSKI ET AL.
April 1998:1035–9 REGIONAL LV FUNCTION DURING MINIMALLY INVASIVE CABG
